Cassava Sciences Inc (SAVA)

Cassava Sciences Inc Aktie (SAVA) Neueste Nachrichten

Cassava Sciences (NASDAQ:SAVA) Trading Up 9.8% - MarketBeat

MarketBeat

Insider Stock Buying Reaches US$831.4k On Cassava Sciences - Simply Wall St

Simply Wall St

Is the Options Market Predicting a Spike in Cassava Sciences (SAVA) Stock? - Yahoo Canada Shine On

Yahoo Canada Shine On

Exclusive-Cassava Sciences faces U.S. criminal probe tied to Alzheimer's drug, sources say - Yahoo Singapore News

Yahoo Singapore News

One to Watch Companies - USA, Cassava Sciences - The Pharma Letter

The Pharma Letter

Cassava Sciences posts $25M profit in Q1 amid Alzheimer's trials - Investing.com South Africa

Investing.com South Africa

Cassava Sciences posts $25M profit in Q1 amid Alzheimer's trials - Investing.com India

Investing.com India

Cassava Sciences posts $25M profit in Q1 amid Alzheimer's trials - Investing.com Canada

Investing.com Canada

Cassava Sciences posts $25M profit in Q1 amid Alzheimer's trials - Investing.com

Investing.com

Cassava swings to Q1 profit as more patients finish simufilam phase 3 trials - Seeking Alpha

Seeking Alpha

Cassava Sciences posts $25M profit in Q1 amid Alzheimer's trials - Investing.com UK

Investing.com UK

Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam - GlobeNewswire

GlobeNewswire

Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam

GlobeNewswire Inc.

Annovis, Anavex, And Cassava Sciences: Trying To Box Oneself Out Of The Alzheimer's Box - Seeking Alpha

Seeking Alpha

(SAVA) Investment Analysis and Advice - Stock Traders Daily

Stock Traders Daily

Cassava Sciences adds over $125M from warrant distribution - Seeking Alpha

Seeking Alpha

Cassava (SAVA) Soars on Encouraging Alzheimer's Study Data - Yahoo New Zealand News

Yahoo New Zealand News

Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution - Yahoo Finance

Yahoo Finance

Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution - Yahoo Finance

Yahoo Finance

Has Cassava Sciences (SAVA) Outpaced Other Medical Stocks This Year? - Yahoo Movies Canada

Yahoo Movies Canada

Are Options Traders Betting on a Big Move in Cassava Sciences (SAVA) Stock? - Yahoo Movies Canada

Yahoo Movies Canada

Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ - GlobeNewswire

GlobeNewswire

Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ

GlobeNewswire Inc.

Stock Market Crash Warning: Don't Get Caught Holding These 3 Biotech Stocks - InvestorPlace

InvestorPlace

Redemption Date Announced for Warrants

GlobeNewswire Inc.

Redemption Date Announced for Warrants - GlobeNewswire

GlobeNewswire

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Cassava Sciences (NASDAQ:SAVA) Sees Unusually-High Trading Volume - MarketBeat

MarketBeat

Cassava Sciences (NASDAQ:SAVA) Stock Price Up 5.7% - MarketBeat

MarketBeat

CASSAVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cassava Sciences, Inc. on Behalf of Long-Term ... - GlobeNewswire

GlobeNewswire

Cassava Sciences, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 2, 2024 deadline. - GlobeNewswire

GlobeNewswire

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with ... - GlobeNewswire

GlobeNewswire

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava ... - PR Newswire

PR Newswire

Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials

GlobeNewswire Inc.

Cassava Sciences' Alzheimer's drug continues Phase 3 trials By Investing.com - Investing.com

Investing.com

Cassava Sciences: Where Did All The Mild Alzheimer's Disease Patients Go? (NASDAQ:SAVA) - Seeking Alpha

Seeking Alpha

Institutions along with individual investors who hold considerable shares inCassava Sciences, Inc. (NASDAQ:SAVA) come under pressure; lose 18% of holdings value - Simply Wall St

Simply Wall St

BA, ORCL, META, SAVA, TSLA: Why These 5 Stocks Are Trending Today - Meta Platforms (NASDAQ:META), Boeing - Benzinga

Benzinga

Cassava Sciences, Inc. to Post FY2024 Earnings of ($2.01) Per Share, HC Wainwright Forecasts (NASDAQ:SAVA) - MarketBeat

MarketBeat

HC Wainwright Weighs in on Cassava Sciences, Inc.'s Q1 2024 Earnings (NASDAQ:SAVA) - MarketBeat

MarketBeat

Cassava Sciences (NASDAQ:SAVA) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

MarketBeat

Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference

GlobeNewswire Inc.

Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference - Yahoo Finance

Yahoo Finance

Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates

GlobeNewswire Inc.

Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates - Yahoo Finance

Yahoo Finance

CASSAVA SCIENCES INVESTOR DEADLINE APPROACHING: Faruqi & - GlobeNewswire

GlobeNewswire

Brian's Big Idea on Low Priced Stocks

Zacks Investment Research

Brian's Big Idea on Low Priced Stocks

Zacks Investment Research

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, and ... - GlobeNewswire

GlobeNewswire

Cassava Sciences And Alzheimer's Disease: Opaque Clarity (NASDAQ:SAVA) - Seeking Alpha

Seeking Alpha